Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use

Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use

US Patent 8604014 · Granted Dec 10, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for neuromodulation of a carotid sinus nerve2025
Methods of treating cancer with an mTOR inhibitor2024
Ras inhibitors2023
SHP2 inhibitor compositions and methods for treating cancer2023
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhib2023
Neuromodulation device and method for treating metabolic disorders2023
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhib2022
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhib2021
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhib2021
Neuromodulation device2021
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer2021
Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibi2021